Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Human Genetics, |
RCV000660333 | SCV000782382 | likely pathogenic | Tuberous sclerosis 1 | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000660333 | SCV001209770 | pathogenic | Tuberous sclerosis 1 | 2024-08-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln328*) in the TSC1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TSC1 are known to be pathogenic (PMID: 10227394, 17304050). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of tuberous sclerosis complex (PMID: 23647917). ClinVar contains an entry for this variant (Variation ID: 547821). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV000660333 | SCV002041097 | pathogenic | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Division of Genomic Medicine, |
RCV000660333 | SCV002559893 | pathogenic | Tuberous sclerosis 1 | 2022-08-01 | criteria provided, single submitter | clinical testing |